Medication
PCOR awards $156 million in new patient-centered health research
New CER studies address critical gaps in sleep health, mental health and developmental care, and maternal health.
WASHINGTON, December 3, 2024 /PRNewswire/ — The Center for Patient-Independent Outcomes Research (PCORI) has received more than $156 million for innovative patient-related research based on clinical effectiveness (CER), as well as research to improve methods and strengthen the science of commitment to CER. The awards will support 13 CER studies, including three focused on sleep.
«Poor sleep affects more than 50 million people United States and is linked to many chronic conditions and adverse health effects,» said PCOR Executive Director Take L. CookMD, MPH. «These patient-centered CER studies will fill important evidence gaps about interventions to improve quality sleep, helping patients and caregivers make better health decisions about this important part of life. they see.»
Among the funding awards for patient-centered CER are:
-
Three studies on care for people with intellectual and developmental disabilities (IDD), including sleep apnea treatment for people with Down syndrome, early intervention for children with and developmental disabilities and travel workshops for youth with IDD.
-
Two studies comparing methods of managing gestational diabetes and postpartum hypertension.
-
Studies dealing with hip fracture, stroke, inflammatory bowel disease, smoking cessation, intubation in adults and follow-up care for bronchiolitis in children.
Funding also supports implementation, CER processes, participatory science and PCORnet®
PCOR has also received financial awards to implement PCOR-funded CER results in clinical practice. One project will help adults with advanced kidney disease understand their treatment options, while another will combine acupuncture and massage therapy in cancer care.
Additional fees include:
-
$8 million for eight courses to improve CER delivery methods.
-
$7 million for four studies to strengthen evidence-based patient engagement with health care decision makers across the design and practice of patient-centered CER.
-
$134 million for PCORnet® supporting the eight PCORnet® Clinical Research Networks (CRNs) and coordinating the activities of the center.
«By investing in methodological research and studies that increase the evidence base for research engagement, we are strengthening the foundation for clinical patient-based research,» said PCOR’s Deputy Executive Director for Patient-Independent Programs. Harv FeldmanMD, MSCE. «Strong, evidence-based and reliable methods are essential to creating research that produces results that patients and their caregivers can rely on. The data from these PCOR-supported studies will continue our work to produce CER with high patient fidelity.»
#PCOR #awards #million #patientcentered #health #research
Strengthening Capacity to Support Growing Demand in the Functional Food Sector
NEW YORK, December 3, 2024 /PRNewswire/ — 5WPR, one of America’s leading and largest independent PR firms, is proud to announce the expansion of its Health & Wellness division to include focusing on Functional Nutrition. This strategic move reflects 5W’s commitment to staying ahead of industry trends and evolving its services to meet the needs of this rapidly changing market.
With increasing consumer interest in functional foods, brands are seeking expert guidance to differentiate themselves in a competitive market. In response, 5WPR has expanded its services to cover key areas within the nutrition industry, including gut health, supplements and functional drinks, performance and sports nutrition, protein powder, probiotics, weight management, collagen peptides, dietary powder, functional mushrooms. , nutrition, and pet health.
Functional nutrition has become an influence in the field of health and wellness, fueled by increased consumer awareness and demand for products that provide more than basic nutritional benefits. According to the latest data from Open PR, gut health products alone are estimated to grow by approximately 8% annually between 2024 and 2031. Additionally, the Food Institute is report that e-commerce has emerged as the fastest growing channel for supplements in 2023, an increase of 9.5%, highlighting the importance of a strong online presence. Performance nutrition has also seen significant growth, with categories such as hydration and electrolytes increasing by 52.2%, and creatine sales increasing by an impressive 114.4%, according to the New Hope Network.
«The functional nutrition market is not only growing; it is defining the health and wellness industry,» he said. Ilisa WirginManaging Partner and EVP of 5WPR’s Health & Wellness and Beauty division. «Consumers are looking for products that improve their overall well-being, improve performance, and support recovery, which makes it an exciting and exciting segment. Our expanded focus will help us helping customers in this area to grow their product profiles, align with their target audience, and deliver meaningful results.»
5WPR’s track record in health and wellness includes working with some of the most recognized brands in fitness, nutrition, and personal care. The agency’s expertise in media relations, influencer partnerships, thought leadership, digital strategy, and affiliate marketing ensures that clients in the nutrition space receive structured, comprehensive, and measurable support.
#5WPR #Expands #Health #Wellness #Divide #Focus #Functional #Nutrition
Your support helps us tell the story
From reproductive rights to climate change to Big Tech, The Independent is breaking new ground as the story unfolds. Whether it’s investigating Elon Musk’s pro-Trump PAC funding or presenting our latest article, ‘The A Word’, which shines a light on American women fighting for reproductive rights, we know how How important is clarity in messages.
At such a critical time in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to talk to both sides of the story.
The Independent is trusted by Americans across all political lines. And unlike many other quality publications, we choose not to block Americans from reporting and reviewing through paywalls. We believe that quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.
Lady Gabriella Kingston’s husband took his own life after taking anti-depressants prescribed by his doctor, a coroner has said.
Thomas Kingston, who married Prince and Princess Michael of Kent’s daughter at Windsor Castle in 2019, died of a head injury and a gun was found next to his body on March 25 at his parents’ home in the Cotswolds.
At an inquest into her death held at Gloucestershire Coroner’s Court on Tuesday, Lady Gabriella, 43, asked people to be warned about the side effects of drugs used to treat mental health conditions or she feared people would many may die.
The inquest was told that the 45-year-old fundraiser had been given sertraline, a drug used to treat depression, and zopiclone, a sleeping pill, by a doctor at the Royal Mews Surgery, Buckingham Palace’s staff-run practice. of the palace. , after complaining of trouble sleeping after stress at work.
Mr Kingston went back to surgery saying they were not making him feel better, and his doctor switched him from sertraline to citalopram, a similar drug.
In the first days of his death, Mr. Kingston had stopped taking medication, and toxicology tests showed caffeine and a small amount of zopiclone in his system.
In a statement read out by Katy Skerrett, chief minister of Gloucestershire, Lady Gabriella, 43, said: «[Work] it has been a challenge for her over the years but I highly doubt it would have made her suicidal, and she seemed to have improved a lot.
If there was something that was bothering him, I’m sure he would have said that he was struggling a lot.
The fact that he committed suicide in the home of his beloved parents suggests that the decision was the result of a sudden impulse.
He said he believed her death «may have been precipitated» by an adverse reaction to medication she had started, and then stopped, taking in the weeks leading up to her death.
«In the absence of any evidence of propensity, it seems very likely to me that she had a bad reaction to the pills that made her take her own life,» Lady Gabriella said.
«I believe that anyone who takes pills like these should be warned about the side effects to prevent future deaths.
If this can happen to Tom, it can happen to anyone.
In his final weeks, Mrs Gabriella said, her husband «seemed normal», except for the morning after he first took zopiclone, which she said made him seem «he he’s a bit confused».
In his statement, he described their marriage as one of «deep love and trust» and said he never gave any suicidal thoughts to himself or others.
He also said he was deeply affected by his friend’s suicide and «the negative impact it had on other people’s loved ones».
Miss Gabriella, whose wedding to Mr Kingston included Queen Elizabeth II and the late Duke of Edinburgh among the guests, wept as she sat in the coroner’s court as her statement was read.
Wrapping up the story, Ms Skerrett said: «Mr Kingston took his own life with a self-inflicted gunshot wound to the head.
«The evidence of his wife, family and business partner all support the lack of intent to kill himself.
He was suffering from the side effects of the medicine he had just been given.»
He said he intends to make a report on the prevention of future deaths, which will be sent to medical societies.
Mr. Kingston’s father, William Martin Kingston, wept as he described finding his son in the locked bathroom of the annexe, having used a doorknob to break the door.
He told the court that his son has always had a strong, unstable character, as he previously suffered from pain that left him needing help to climb the stairs.
She told the coroner that before her son’s death there did not appear to be any evidence of suicide, and there was no will, describing the process as «reckless.» very» who was «out of shape».
Dr David Healy, a psychiatrist who gave evidence at the hearing, said zopiclone could also cause anxiety, while sertraline and citalopram were both serotonin reuptake inhibitors (SSRIs), and while exactly the same.
Dr Healy said Mr Kingston’s complaints that sertraline continued to cause him anxiety was a sign SSRIs «didn’t suit him», and he should not have been prescribed the same thing again.
He said the guidelines and labels for SSRIs were not clear enough about using the drug first, or what the effect would be when switching from one to another.
He said: «We need a clearer statement that these drugs can cause people to kill themselves who would otherwise not kill themselves.
Speaking to the doctor, Martin Porter, the family’s adviser, said: «The family is not to blame (her doctor) Dr Naunton Morgan, he worked like a good doctor.
But the question is whether there is enough advice to doctors about SSRIs.
#Lady #Gabriellas #husband #killed #antidepressants
AlayaCare’s Cloud-Based EHR Platform Onboards Home Care Benefits of the Home Care Center
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) — AlayaCare, a global technology platform for home and community care, is pleased to announce today the successful implementation of Care Advantage, Inc.
Care Advantage, Inc. is the largest independent home health provider in the mid-Atlantic. The company provides personal services, home care and home health services throughout Virginia, Maryland, Delaware, North Carolina and Washington DC.
Care Advantage’s leadership recognized AlayaCare’s ability to provide a risk-free, user-friendly solution that could grow with the company. The decision to collaborate with AlayaCare was made after an extensive selection process that considered the opinions of experts from its internal teams, emphasizing the importance of a holistic approach to choosing a technology partner.
«We were looking for a partner, not just a vendor, who could help us build and transform our system over time,» said Tim Hanold, CEO of Care Advantage. «AlayaCare’s commitment to working together and creating a true partnership were key factors in our final decision.»
Despite the challenges presented by the published timeline and coverage of more than 50 locations, both teams worked closely to customize the system to meet Care Advantage’s needs.
«Implementing a system of this size in such a short period of time was no small feat,» said Jaron Clay, VP of Integrations. «The speed of the rollout was only possible with good coordination and both groups are committed to having Care Advantage running smoothly and feeling the benefits of the new system as soon as possible.»
The move to AlayaCare underscores Care Advantage’s commitment to innovation and excellence in home care, ensuring clients and their families receive the best possible care and support. As a highly data-driven and growth-focused company, the flexibility of AlayaCare’s platform enables large operations to enter new markets while maintaining a high level of customer care. own and create new opportunities for its custodians.
«There is a shared understanding and vision between us and the AlayaCare team,» said Tim Hanold. «They support our unwavering commitment to excellence in the classroom and are part of the reason we chose them. We feel this is the platform to take us to that level. We are delighted to have AlayaCare as a partner our technology,» he concluded. «Together, we’re setting new standards for home care.»
#AlayaCares #CloudBased #EHR #Platform #Onboards #Home #Care #Benefits #Home #Care #Center
-
Medication9 meses agoLady Gabriella’s husband ‘killed himself after taking antidepressants’
-
Medication9 meses ago5WPR Expands Health and Wellness Divide with New Focus on Functional Nutrition
-
Health care9 meses agoPilot program brings culinary medicine to PA students
-
Health care9 meses agoGlobal Sports and Food Aging Food and Beverage Market 2024 to 2031
-
Medication9 meses agoAlayaCare’s Cloud-Based EHR Platform Onboards Home Care Benefits of the Home Care Center
-
Mental health9 meses agoText message reminders fail to boost long-term medication use
-
Medication9 meses agoOncology Nutrition Market Next Big Thing | Big Giants- Nestle, Sofina, Reckitt Benckiser
-
Health care9 meses ago7 Ways Tech Can Improve Your Mental Health